Silverback Therapeutics, Inc.
ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF

Last updated:

Abstract:

Compounds, conjugates and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed compounds may be useful, among other things, in treating of cancer and inhibiting ALKS. Compounds incorporated into a conjugate with an antibody construct are also described herein.

Status:
Application
Type:

Utility

Filling date:

2 Apr 2019

Issue date:

27 May 2021